Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
J Nucl Cardiol ; 29(4): 1976-1984, 2022 08.
Article in English | MEDLINE | ID: mdl-33948890

ABSTRACT

BACKGROUND: Breast attenuation artifacts occurring with upright cadmium-zinc-telluride (CZT) cardiac imaging systems have not been well characterized. METHODS: 216 consecutive patients with Single Photon Emission Computerized Tomography myocardial perfusion imaging and no angiographically significant obstructive coronary artery disease were identified. All upright and supine SPECT images as well as coronary angiograms were reviewed and analyzed in blinded fashion. RESULTS: In women imaged upright, more visual false positive defects were noted in the inferior wall compared to the anterior wall (26 vs. 10 at rest, p = 0.006, and 33 vs. 13 at stress, p < 0.001). Visual inferior wall defects were more common in the upright than supine position at stress (33 vs. 23, p = 0.018) and rest (26 vs. 14, p = 0.011), and most apparent in non-obese women (13 vs. 8, at stress, p = 0.059 and 11 vs. 5, at rest, p = 0.014). CONCLUSIONS: With upright CZT myocardial perfusion imaging, women often have visible inferior wall attenuation artifact defects, likely from pendant breast tissue. These inferior wall attenuation artifacts may be seen in non-obese female patients.


Subject(s)
Coronary Artery Disease , Myocardial Perfusion Imaging , Artifacts , Cadmium , Coronary Angiography , Coronary Artery Disease/diagnostic imaging , Female , Humans , Male , Myocardial Perfusion Imaging/methods , Tellurium , Tomography, Emission-Computed, Single-Photon/methods , Zinc
2.
Interv Cardiol ; 17: e16, 2022 Jan.
Article in English | MEDLINE | ID: mdl-36644625

ABSTRACT

Anomalous aortic origin of a coronary artery is a rare congenital anomaly and potential aetiology for sudden cardiac death. However, the mere presence of this anomaly does not portend clinical significance, and there are many factors that contribute to limiting coronary blood flow in these patients. The standard of care for symptomatic individuals is surgical management with coronary unroofing although not all cases are amenable to surgery. We report the case of an anomalous right coronary artery with interarterial course managed by percutaneous coronary intervention due to surgical contraindication secondary to comorbidities. The proposed mechanism of action culminating in aborted sudden cardiac death is unique and involves aggravated pulmonary hypertension in an individual with severe comorbid pulmonary disease.

3.
JACC Case Rep ; 3(11): 1382-1383, 2021 Sep 01.
Article in English | MEDLINE | ID: mdl-34505077

ABSTRACT

The S1S2S3 pattern, in conjunction with right-dominant forces on a 12-lead electrocardiogram including a tall R-wave in lead V1 (R:S >1), deep S waves in the left precordial leads V5 and V6 (R:S <1), QRS interval <120 ms, and right atrial enlargement (P-wave in lead II >2.5 mm), is highly specific for right ventricular dysfunction with pulmonary hypertension. (Level of Difficulty: Intermediate.).

4.
Diagnostics (Basel) ; 11(1)2021 Jan 15.
Article in English | MEDLINE | ID: mdl-33467705

ABSTRACT

Myocardial injury is a common complication of the COVID-19 illness and is associated with a worsened prognosis. Systemic hyperinflammation seen in the advanced stage of COVID-19 likely contributes to myocardial injury. Cardiac magnetic resonance imaging (CMR) is the preferred imaging modality for non-invasive evaluation in acute myocarditis, enabling risk stratification and prognostication. Modified scanning protocols in the pandemic setting reduce risk of exposure while providing critical data regarding cardiac tissue inflammation and fibrosis, chamber remodeling, and contractile function. The growing use of CMR in clinical practice to assess myocardial injury will improve understanding of the acute and chronic sequelae of myocardial inflammation from various pathological etiologies.

5.
J Nucl Cardiol ; 28(4): 1569-1582, 2021 08.
Article in English | MEDLINE | ID: mdl-31489586

ABSTRACT

BACKGROUND: Limited data address the roles of gender, perfusion defect reversibility, and imaging position in interpretation of images acquired on an upright/supine cadmium-zinc-telluride (CZT) cardiac imaging system. METHODS AND RESULTS: From a consecutive cohort of patients imaged on an upright/supine CZT camera, 260 patients with coronary angiograms were studied. Multivariable models identified gender as a significant effect modifier for imaging variables of CAD. For males, a supine summed stress score (SSS) ≥ 3 provided high accuracy (sensitivity 70.7%, specificity 72.2%), and highest contribution to multivariable models. In females, supine SSS ≥ 2 provided the best cut-off for defect size and severity (sensitivity 90%, specificity 35.9%), but specificity was improved substantially to 53.3% with decrease in sensitivity to 80% by also requiring quantitative identification of perfusion defect reversibility in the supine position. Eight variables, accurate for predicting coronary disease, were more accurate with supine than upright imaging. CONCLUSIONS: Perfusion defect reversibility improved specificity in female patients for detection of coronary disease compared to perfusion defect size and extent alone. Supine images provided superior accuracy for detection of coronary disease compared to upright images.


Subject(s)
Cadmium , Coronary Artery Disease/diagnostic imaging , Gamma Cameras , Myocardial Perfusion Imaging , Patient Positioning , Tellurium , Tomography, Emission-Computed, Single-Photon , Zinc , Aged , Cohort Studies , Coronary Angiography , Female , Humans , Male , Middle Aged , Sensitivity and Specificity , Sex Factors , Sitting Position , Supine Position
6.
J Thromb Thrombolysis ; 47(1): 1-7, 2019 Jan.
Article in English | MEDLINE | ID: mdl-30328054

ABSTRACT

Stress-induced cardiomyopathy (SCM), is a reversible cardiomyopathy characterized by transient systolic dysfunction following an acute physiologic stress. Thromboembolism occurs at a high frequency in patients with intracardiac thrombus secondary to SCM, with one systematic review reporting a rate of 33.3%. The risk of thrombus formation following SCM has been associated with left-ventricular (LV) contraction abnormalities, catecholaminergic surge, and other associated comorbidities. However, established guidelines for screening and management of intracardiac thrombus in the setting of SCM do not exist at present due to a lack of sufficient clinical trial data. The purpose of this article is to discuss the pathophysiological theory and previously documented evidence from cases of LV thrombus secondary to SCM, and to present our recommendations for management of intracardiac thrombus secondary to SCM.


Subject(s)
Anticoagulants/therapeutic use , Cardiomyopathies/complications , Stress, Physiological , Thrombosis/etiology , Cardiomyopathies/drug therapy , Cardiomyopathies/etiology , Disease Management , Humans , Thromboembolism/drug therapy , Thromboembolism/etiology , Thrombosis/drug therapy
7.
J Thromb Thrombolysis ; 47(1): 157-161, 2019 Jan.
Article in English | MEDLINE | ID: mdl-30269287

ABSTRACT

The incidence of acute myocardial infarction in the setting of acute pancreatitis is very rare. The recognition of such complex diagnosis may be clinically challenging, as the symptoms of both conditions are often indistinguishable. We report a case in which we encountered both conditions concurrently, and hypothesize that the ambient inflammatory and pro-thrombotic milieu of acute pancreatitis resulted in acute coronary thrombosis despite the absence of significant coronary atherosclerosis. Among multiple coronary imaging modalities currently in use, optimal cohesion tomography provided a unique capability for direct visualization of the coronary thrombus. (1) Inflammatory processes such as acute pancreatitis promote a thrombogenic state. (2) Presentation of acute myocardial infarction is variable and can mimic a variety of medical conditions. (3) Intravascular imaging is emerging as a useful tool in delineating details of intra-coronary pathology not clear on standard fluoroscopy. (4) The above case highlights the likely concurrence of pathologies that follow common pathways such as system-wide inflammation and coagulation. Clinicians must be aware of this uncommon yet very likely possibility and keep a low threshold to perform ECG and cardiac biomarker testing if symptoms are suggestive of a myocardial infarction, even in the presence of a clear alternative diagnosis.


Subject(s)
Coronary Thrombosis/etiology , Pancreatitis/complications , Blood Coagulation , Coronary Thrombosis/diagnostic imaging , Endovascular Procedures , Humans , Inflammation , Myocardial Infarction/diagnosis , Tomography, Optical Coherence
8.
J Hematol Oncol ; 8: 109, 2015 Oct 06.
Article in English | MEDLINE | ID: mdl-26444865

ABSTRACT

IMPORTANCE: Small cell carcinoma/neuroendocrine prostate cancer (NePC) is a lethal, poorly understood prostate cancer (PCa) subtype. Controversy exists about the origin of NePC in this setting. OBJECTIVE: To molecularly profile archived biopsy specimens from a case of early-onset PCa that rapidly progressed to NePC to identify drivers of the aggressive course and mechanisms of NePC origin and progression. DESIGN, SETTING, AND PARTICIPANTS: A 47-year-old patient presented with metastatic prostatic adenocarcinoma (Gleason score 9). After a 6-month response to androgen deprivation therapy, the patient developed jaundice and liver biopsy revealed exclusively NePC. Targeted next generation sequencing (NGS) from formalin-fixed paraffin-embedded (FFPE)-isolated DNA was performed from the diagnostic prostate biopsy and the liver biopsy at progression. INTERVENTION: Androgen deprivation therapy for adenocarcinoma followed by multiagent chemotherapy for NePC. MAIN OUTCOMES AND MEASURES: Identification of the mutational landscape in primary adenocarcinoma and NePC liver metastasis. Whether the NePC arose independently or was derived from the primary adenocarcinoma was considered based on mutational profiles. RESULTS: A deleterious somatic SMAD4 L535fs variant was present in both prostate and liver specimens; however, a TP53 R282W mutation was exclusively enriched in the liver specimen. Copy number analysis identified concordant, low-level alterations in both specimens, with focal MYCL amplification and homozygous PTEN, RB1, and MAP2K4 losses identified exclusively in the NePC specimen. Integration with published genomic profiles identified MYCL as a recurrently amplified in NePC. CONCLUSIONS AND RELEVANCE: NGS of routine biopsy samples from an exceptional non-responder identified SMAD4 as a driver of the aggressive course and supports derivation of NePC from primary adenocarcinoma (transdifferentiation).


Subject(s)
Adenocarcinoma/drug therapy , Androgen Antagonists/therapeutic use , Carcinoma, Small Cell/drug therapy , High-Throughput Nucleotide Sequencing/methods , Prostatic Neoplasms/drug therapy , Adenocarcinoma/genetics , Adenocarcinoma/pathology , Carcinoma, Small Cell/genetics , Carcinoma, Small Cell/pathology , Cell Transdifferentiation/genetics , Disease Progression , Gene Expression Profiling , Gene Expression Regulation, Neoplastic , Genetic Predisposition to Disease/genetics , Humans , Male , Middle Aged , Neoplasm Metastasis , Prostatic Neoplasms/genetics , Prostatic Neoplasms/pathology , Smad4 Protein/genetics , Treatment Outcome
9.
Recent Pat Drug Deliv Formul ; 9(2): 158-66, 2015.
Article in English | MEDLINE | ID: mdl-25612744

ABSTRACT

Less than 8.5% of ischemic stroke patients receive clot-busting drugs within the narrow time needed to reduce injury. Thus, there is need for an easily-accessible delayed post-stroke drug treatment to improve functional recovery. Various combinations of fluoxetine, simvastatin, and ascorbic acid were given to healthy rats to assess impact on neurogenesis versus controls. Fluoxetine combined with simvastatin and ascorbic acid produced a 19-fold increase in neurogenesis versus controls in healthy rats; fluoxetine alone produced 10-fold increase. We next tried a couple of drug combinations versus control in endothelin-induced stroked rats. Combined fluoxetine/ simvastatin/ascorbic acid treatment, given to stroked rats 20-26 hours after stroke induction and continued for 31 days, produced strong recovery as measured by Montoya staircase test (mean recovery to 85% of pre-stroke function) and Forelimb Asymmetry test (mean recovery to 90% of pre-stroke function). Fluoxetine and ascorbic acid without simvastatin only produced ~50% of recovery produced by the 3-drug combination. Our results indicate that combined treatment of Fluoxetine, simvastatin and ascorbic acid represents a promising delayed stroke treatment that greatly improves functional recovery in rats and warrants further study in human patient populations. This work formed the basis for a patent submission (US20130065924A1) Composition and method for treatment of neurodegeneration.


Subject(s)
Ascorbic Acid/administration & dosage , Brain Ischemia/drug therapy , Fluoxetine/administration & dosage , Neurogenesis/drug effects , Simvastatin/administration & dosage , Stroke/drug therapy , Animals , Brain/drug effects , Brain/pathology , Brain Ischemia/pathology , Drug Therapy, Combination , Female , Male , Rats , Rats, Long-Evans , Rats, Wistar , Recovery of Function/drug effects , Stroke/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...